Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer

Biological Chemistry

Volumn 385, Issue 9, 2004, Pages 779-783

  Mathioudaki, Konstantina ^a   Scorilas, Andreas ^b   Papadokostopoulou, Alexandra ^a   Xynopoulos, Dimitrios ^a   Arnogianaki, Niki ^a   Agnanti, Niki ^c   Talieri, Maroulio ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Apoptosis; BCL2L12; Colon cancer

Indexed keywords

PROTEIN; PROTEIN BCL 2; PROTEIN BCL 2 L12; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER TISSUE; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; COLONIC NEOPLASMS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HUMANS; MIDDLE AGED; MUSCLE PROTEINS; PROPORTIONAL HAZARDS MODELS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-BCL-2; STATISTICS, NONPARAMETRIC;

EID: 5044222818     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2004.101     Document Type: Article

References (20)

1. Adams, J.M. and Cory, S. (1998). The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322-1326.
2. Choi, W.S., Yoon, S.Y., Chang, I.I., Choi, E.J., Rhim, H., Jin, B.K., Oh, T.H., Krajewski, S., Reed, J.C., and Oh, Y.J. (2000). Correlation between structure of Bcl-2 and its inhibitory function of JNK and caspase activity in dopaminergic neuronal apoptosis. J. Neurochem. 74, 1621-1626.
3. Floros, K.V., Thomadaki, H., Lallas, G., Katsaros, N., and Talieri, M. (2003). Cisplatin-induced apoptosis in HL-60 human promyelocytic leukemia cells: differential expression of Bcl2 and novel apoptosis-related gene BCL2L12. Ann. NY Acad. Sci. 1010, 153-158.
4. Kanavaros, P., Stefanaki, K., Valassiadou, K., Vlachonikolis, J., Mavromanolakis, M., Vlychou, M., Kakolyris, S., Gorgoulis, V., Tzardi, M., and Georgoulias, V. (1999). Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins colorectal adenocarcinomas. Med. Oncol. 16, 23-30.
5. Korsmeyer, S.J. (1999). BCL-2 gene family and the regulation of programmed cell death. Cancer Res. 59, 1693s-1700s.
6. Leahy, D.T., Mulcahy, H.E., O'Donoghue, D.P., and Parfrey, N.A. (1999). Bcl-2 protein expression is associated with better prognosis in colorectal cancer. Histopathology 35, 360-367.
7. Mariadason, J.M., Arango, D., Shi, Q., Wilson, A., Corner, G., Nicholas, C., Aranes, M., Lesser, M., Schwartz, E., and Augenlicht, L.H. (2003). Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothesin. Cancer Res. 63, 8791-8812.
8. Meterissian, S.H., Kontogiannea, M., A-Sowaidi, M., Linjawi, A., Halwan, A., Jamison, B., and Edwardes, M. (2001). Bcl-2 is a useful prognostic marker in Dukes' B colon cancer. Ann. Surg. Oncol. 8, 533-537.
9. Nahta, R., and Esteva, F.J. (2003). Bcl-2 antisense oligonucleotides: a potential novel strategy for the treatment of breast cancer. Semin. Oncol. 30 (Suppl. 16), 143-149.
10. Ogura, E., Senzaki, H., Yamamoto, D., Yoshida, R., Takada, H., Hioki, K., and Tsubura, A. (1999). Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas. Oncol. Rep. 6, 365-369.
11. Reed, J.C. (1999). Dysregulation of apoptosis in cancer. J. Clin. Oncol. 17, 2941-2953.
12. Reed, J.C. (2002). Apoptosis-based therapies. Nat. Rev. Drug Dis. 1, 111-121.
13. Reed, J.C. (2003). Apoptosis-targeted therapies in cancer. Cancer Cell 3, 17-22.
14. Reed, J.C., Zha, H., Aime-Sempe, C., Takayama, S., and Wang, H.G. (1996). Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death. Adv. Exp. Med. Biol. 406, 99-112.
15. Scorilas, A., Black, M.H., Talieri, M., and Diamandis, E.P. (2000). Genomic organization of the human protein arginine methyltransferase 1 gene (PRMT1): differential expression of splice variants in breast cancer. Biochem. Biophys. Res. Commun. 278, 349-359.
16. Scorilas, A., Kyriakopoulou, L., Yousef, G., Ashworth, L., Kwamie, A. and Diamandis, E.P. (2001). Molecular cloning, physical mapping and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH3 domain of the Bcl-2 family. Genomics 72, 217-221.
17. Sjostrom, J., Blomqvist, C., von Boguslawski, K., Bengtsson, N.O., Mjaaland, I., Malmstrom, P., Ostenstadt, B., Wist, E., Valvere, V., Takayama, S., Reed, J.C., and Saksela, E. (2002). The predictive value of bcl-2, bax, bcl-XI, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer. Clin. Cancer Res. 8, 811-816.
18. Sun, X.F., Bartik, Z., and Zhang, H. (2003). Bcl-2 expression is a prognostic factor in the subgroups of patients with colorectal cancer. Int. J. Oncol. 23, 1439-1443.
19. Talieri, M., Diamandis, E.P., Katsaros, N., Gourgiotis, D., and Scorilas, A. (2003). Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors. Thromb. Haemost. 89, 1081-1088.
20. Tamm, I., Schriever, F., and Dorken, B. (2001). Apoptosis implications of basic research for clinical oncology. Lancet Oncol. 2, 33-42.